A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and ...

Dr. Hong’s longstanding commitment to innovation and compassion for his patients made him a pioneer in bringing the TULSA Procedure, a clinically proven, advanced prostate disease treatment, to ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets artificial intelligence (“AI”)-powered, MRI-guided, ...

HistoSonics is developing a non-invasive therapy that uses histotripsy, a therapeutic focused ultrasound energy, to destroy ...

Revenue grew 87% year-over-year to a record $5.3 million in the third quarter of 2025. Gross margin increased 1,119 basis points year-over-year to 74.3% in Q3-2025. The Company’s TULSA-PRO ® qualified ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

Barely an hour after being wheeled into a clinical space at Oregon Health & Science University on Aug. 27, an Arkansas woman emerged with vastly improved symptoms of the Parkinson's disease that had ...

A pioneering new liver cancer treatment, employing focused ultrasound waves to destroy diseased tissue, has been administered to the first NHS patient. Addenbrooke’s Hospital in Cambridge is the first ...

In Gaza, a patient’s suffering does not end at diagnosis. The Israeli blockade has turned obtaining any medical supplies into ...

I OFTEN get questions about an uncomfortable bowel condition called diverticulosis. It’s common in those over 50 and is where ...